124 related articles for article (PubMed ID: 37085424)
21. Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma.
Wang Q; Tang H; Luo X; Chen J; Zhang X; Li X; Li Y; Chen Y; Xu Y; Han S
Front Immunol; 2022; 13():890150. PubMed ID: 35686121
[TBL] [Abstract][Full Text] [Related]
22. Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing.
Lin PH; Huang CY; Yu KJ; Kan HC; Liu CY; Chuang CK; Lu YC; Chang YH; Shao IH; Pang ST
Oncol Lett; 2021 Feb; 21(2):169. PubMed ID: 33456545
[TBL] [Abstract][Full Text] [Related]
23. Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
Bui TO; Dao VT; Nguyen VT; Feugeas JP; Pamoukdjian F; Bousquet G
Eur Urol; 2022 Apr; 81(4):349-361. PubMed ID: 34991918
[TBL] [Abstract][Full Text] [Related]
24. The genomics of renal cell carcinoma and its role in renal mass biopsy.
Salami SS; George AK; Udager AM
Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
[TBL] [Abstract][Full Text] [Related]
25. Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.
Kluzek K; Srebniak MI; Majer W; Ida A; Milecki T; Huminska K; van der Helm RM; Silesian A; Wrzesinski TM; Wojciechowicz J; Beverloo BH; Kwias Z; Bluyssen HAR; Wesoly J
Oncotarget; 2017 Apr; 8(17):28558-28574. PubMed ID: 28212566
[TBL] [Abstract][Full Text] [Related]
26. Loss of PBRM1 expression is associated with renal cell carcinoma progression.
Pawłowski R; Mühl SM; Sulser T; Krek W; Moch H; Schraml P
Int J Cancer; 2013 Jan; 132(2):E11-7. PubMed ID: 22949125
[TBL] [Abstract][Full Text] [Related]
27. Tumor microenvironment immune subtypes for classification of novel clear cell renal cell carcinoma profiles with prognostic and therapeutic implications.
Wang Q; Hu J; Kang W; Wang J; Xiang Y; Fu M; Gao H; Huang Z
Medicine (Baltimore); 2021 Mar; 100(11):e24949. PubMed ID: 33725966
[TBL] [Abstract][Full Text] [Related]
28. Clonal architectures predict clinical outcome in clear cell renal cell carcinoma.
Huang Y; Wang J; Jia P; Li X; Pei G; Wang C; Fang X; Zhao Z; Cai Z; Yi X; Wu S; Zhang B
Nat Commun; 2019 Mar; 10(1):1245. PubMed ID: 30886153
[TBL] [Abstract][Full Text] [Related]
29. Mutations in renal cell carcinoma.
D'Avella C; Abbosh P; Pal SK; Geynisman DM
Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
[TBL] [Abstract][Full Text] [Related]
30. Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients.
Saout JR; Lecuyer G; Léonard S; Evrard B; Kammerer-Jacquet SF; Noël L; Khene ZE; Mathieu R; Brunot A; Rolland AD; Bensalah K; Rioux-Leclercq N; Lardenois A; Chalmel F
Eur Urol; 2023 May; 83(5):441-451. PubMed ID: 36801089
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma.
Weaver C; Bin Satter K; Richardson KP; Tran LKH; Tran PMH; Purohit S
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428521
[TBL] [Abstract][Full Text] [Related]
32. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine.
Audenet F; Yates DR; Cancel-Tassin G; Cussenot O; Rouprêt M
BJU Int; 2012 Jun; 109(12):1864-70. PubMed ID: 22035299
[TBL] [Abstract][Full Text] [Related]
33. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
34. Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma.
He X; Tian F; Guo F; Zhang F; Zhang H; Ji J; Zhao L; He J; Xiao Y; Li L; Wei C; Huang C; Li Y; Zhang F; Yang B; Ye H; Wang F
BMC Med; 2022 Aug; 20(1):270. PubMed ID: 36002886
[TBL] [Abstract][Full Text] [Related]
35. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
[TBL] [Abstract][Full Text] [Related]
36. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.
Brooks SA; Brannon AR; Parker JS; Fisher JC; Sen O; Kattan MW; Hakimi AA; Hsieh JJ; Choueiri TK; Tamboli P; Maranchie JK; Hinds P; Miller CR; Nielsen ME; Rathmell WK
Eur Urol; 2014 Jul; 66(1):77-84. PubMed ID: 24613583
[TBL] [Abstract][Full Text] [Related]
37. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
Gao J; Ye F; Han F; Jiang H; Zhang J
Front Immunol; 2022; 13():956679. PubMed ID: 36177018
[TBL] [Abstract][Full Text] [Related]
38. Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course.
DiNatale RG; Gorelick AN; Makarov V; Blum KA; Silagy AW; Freeman B; Chowell D; Marcon J; Mano R; Sanchez A; Attalla K; Weng S; Voss M; Motzer RJ; Russo P; Coleman JA; Reuter VE; Chen YB; Chan TA; Reznik E; Tickoo SK; Hakimi AA
Eur Urol Focus; 2021 Mar; 7(2):381-389. PubMed ID: 31813809
[TBL] [Abstract][Full Text] [Related]
39. Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients.
Jiang W; Zeng H; Liu Z; Jin K; Hu B; Chang Y; Liu L; Zhu Y; Xu L; Wang Z; Guo J; Xu J
Urol Oncol; 2022 Apr; 40(4):166.e15-166.e25. PubMed ID: 34998671
[TBL] [Abstract][Full Text] [Related]
40. The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling.
Sankin A; Hakimi AA; Mikkilineni N; Ostrovnaya I; Silk MT; Liang Y; Mano R; Chevinsky M; Motzer RJ; Solomon SB; Cheng EH; Durack JC; Coleman JA; Russo P; Hsieh JJ
Cancer Med; 2014 Dec; 3(6):1485-92. PubMed ID: 25124064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
